Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
The current price of ISR is $0.38 USD — it has decreased by -1.04% in the past 24 hours. Watch IsoRay stock price performance more closely on the chart.
What is IsoRay stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange IsoRay stocks are traded under the ticker ISR.
What is IsoRay market cap?▼
Today IsoRay has the market capitalization of 54M
What is IsoRay revenue for the last year?▼
IsoRay revenue for the last year amounts to 10.8M USD.
What is IsoRay net income for the last year?▼
ISR net income for the last year is -7.27M USD.
How many employees does IsoRay have?▼
As of April 02, 2026, the company has 61 employees.